プレスリリース
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2009
- 2008
- 2007
- 2006
- 2000
- 1999
-
- 30Oct
-
Sabinsa’s Curcumin C3 Complex® and Aspirin Combination Researched in Groundbreaking Colorectal Cancer Study
- 10Oct
-
Sami-Sabinsa Group Opens 2nd Continuous Extraction Facility to Meet Demand for Curcumin C3 Complex® and Other Extracts
- 19Jun
-
Sabinsa’s Curcumin C3 Complex® With Bioperine® Shows Protective Role In Lipid Profile Modification In Type 2 Diabetes In Published Study
- 15Apr
-
Olive Lifesciences to pay Sabinsa $ 2.2 million
- 11Apr
-
Sabinsa Takes Action Against BioTikon For Synthetic Curcumin Adulteration
- 04Apr
-
Court Orders Olive Lifesciences to Pay Sabinsa $2.2 Million for Willfull Infringement
- 06Feb
-
Sabinsa’s Curcumin C3 Complex® Studied For Antioxidant Effect In Diabetes Patients
-
- 21Nov
-
U.S. District Court Holds Aegle Bios Liable for Willful Infringement of Sabinsa’s Tetrahydrocurcuminoid Patent
- 27Sep
-
Sabinsa To Highlight Recent Published Studies, New Canadian Health Claims At Supplyside West
- 17Aug
-
Sabinsa Europe And Healthspan Ltd Enter Into Curcumin C3 Complex® Supply Agreement
-
- 31Aug
-
Sabinsa To Highlight Cognitive Health Benefits Of Curcumin And Bacopa In Cognitive Health Online Summit On September 2nd
- 25Jun
-
Indian Police Impound Synthetic Curcumin;Results Of Additional Tests Reveal More Synthetic Curcumin
- 16Jun
-
UK Study Shows Sabinsa's Curcumin C3 Complex® To Be Safe Adjunct To, And Enhance Efficacy Of, Folfox Chemotherapy
- 01Jun
-
Sabinsa Takes Legal Action Against Curcumin Adulteration
- 19May
-
Sabinsa's Curcumin C3 Complex® Shows Significant Benefits In Lipid Levels In Patients With Coronary Artery Disease
- 02Mar
-
Sabinsa Patent Infringement Litigation Against Prakruti Settled: Curcumin C3 Complex® Patent Successfully Defended
- 25Mar
-
Sabinsa Once More Successfully Protects Curcumin C3 Complex® Patent Infringement Litigation Against Herbakraft Settled
-
- 07Nov
-
Sabinsa Features Proprietary Curcumin, Enzymes And Powdered Coconut At Supplyside West
- 15Oct
-
Sabinsa's Curcumin Receives GRAS No Comment Letter From FDA
- 19Feb
-
Sabinsa Launches Next Generation Of Curcumin, Resolving Potency, Color, Dosage, Stability And Bioavailability Concerns: Curcumin C3 Reduct®
-
- 04Aug
-
Sabinsa Corporation Receives GRAS Status For Award Winning Branded Ingredient Curcumin C3 Complex®
- 02Mar
-
Sabinsa intellectual property strengthen with granting of two additional international patents
- 25Feb
-
Sabinsa releases position paper on turmeric safety
- 16Feb
-
Sabinsa Receives NBJ 2008 Supplement Ingredient Product Merit Award For Curcumin C3 Complex®
- 09Jan
-
Position Paper on Oxalate in Turmeric
-
- 18Aug
-
Sabinsa’s Curcumin C3 Complex® Subject of Recent Pancreatic Cancer Study Results suggest branded curcumin ingredient efficacious with some patients
-
- 15Mar
-
Sabinsa Corporation Receives Two Business Achievement Awards From Nutrition Business Journal
-
- 27Jan
-
Sabinsa Corporation Receives U.S. patent on Curcumin C3 Complex®